Korea News
-
Korea's LOTTE buys Bristol Myers Squibb's US facility for expanding CDMO biz
Korea | News | 0 Comment | 16 May, 2022
South Korean firm LOTTE has agreed to purchase Bristol Myers Squibb’s manufacturing facility in East Syracuse, New...Read more
-
GenScript ProBio builds up presence in APAC
Korea | News | 0 Comment | 13 May, 2022
GenScript ProBio, a global CDMO company from GenScript Biotech Corporation, has announced the opening of a legal entity ...Read more
-
Korea to open new chapter in world's antiviral drug history
Korea | News | 0 Comment | 12 May, 2022
The birth of a universal antiviral drug with a mechanism applicable to all viral infections is approaching. This antivir...Read more
-
UK inks agreement with Korea for disease control and prevention
Korea | News | 0 Comment | 09 May, 2022
Dr Dame Jenny Harries, Chief Executive of the UK Health Security Agency (UKHSA), has signed a Memorandum of Understandin...Read more
-
Korea builds deep learning model to predict adverse drug-drug interactions
Korea | News | 0 Comment | 06 May, 2022
The intake of multiple drugs can result in adverse health effects due to unexpected drug-drug interactions (DDIs). Now, ...Read more
-
Korea develops wireless brain neurochemical system to study Parkinson’s disease
Korea | News | 0 Comment | 04 May, 2022
A group of researchers at Korea University have developed an electronic medical system that can be inserted into de...Read more
-
SK bioscience reaches final stage of developing Korea´s first COVID-19 vaccine
Korea | News | 0 Comment | 02 May, 2022
South Korea-based SK bioscience and GSK have announced submission of a biologics license application for SKYCovione a re...Read more
-
South Korean firms lay focus on immune cell therapy
Korea | News | 0 Comment | 29 Apr, 2022
Daewoong Pharmaceutical has signed a joint research and development agreement with UCI Therapeutics (CEO Sooyoung Jung),...Read more
-
Korean firm GC Biopharma explores use of lipid nanoparticle delivery system in mRNA vaccines
Korea | News | 0 Comment | 28 Apr, 2022
GC Biopharma, based in South Korea, and Canadian firm Acuitas Therapeutics, a company focused on developing lipid nanopa...Read more
-
Korea | News | 0 Comment | 27 Apr, 2022
Korea's PharmAbcine Inc., a clinical-stage biotech company focusing on the development of next-generation antibody thera...Read more
-
Korea's Seegene unveils world's first commercialised '3 Ct' PCR assay
Korea | News | 0 Comment | 27 Apr, 2022
Seegene Inc., South Korea's leading molecular diagnostics (MDx) company, has announced the development of the ...Read more
-
Adge Pharma, Cyan Bio advance treatments for rare paediatric diseases in Asian countries
Korea | News | 0 Comment | 26 Apr, 2022
Adge Pharmaceuticals has entered into a license agreement with South Korea-based Cyan Bio, Inc. Cyan will receive exclus...Read more
-
Korean firm Vuno partners with Mayo Clinic for AI-based precision oncology
Korea | News | 0 Comment | 25 Apr, 2022
South Korea-based startup Vuno has signed a research agreement with Mayo Clinic in the US. The research agreement, which...Read more
-
Korea develops COVID-19 detection platform by 'slowing down light'
Korea | News | 0 Comment | 22 Apr, 2022
A research group led by Professor Young Min Song of the Gwangju Institute of Science and Technology in Korea h...Read more
-
Korea's LG Chem pushes targeting of global atopic dermatitis market worth KRW 29 trillion
Korea | News | 0 Comment | 21 Apr, 2022
South Korea's LG Chem has announced that its Chinese counterpart TransThera Sciences received the IND clearance fro...Read more
-
Korean firm GC buys US-based CDMO BioCentriq to enhance global capabilities
Korea | News | 0 Comment | 20 Apr, 2022
GC corp., the holding (system) company for GC group in South Korea with major operating companies across healthcare se...Read more
-
GeneQuantum and AIMEDBIO collaborate on a first-in-class antibody drug conjugate
Korea | News | 0 Comment | 19 Apr, 2022
China's GeneQuantum Healthcare, a company specializing in site-specific bioconjugation for next generation biotherapeuti...Read more
-
Korea's Bridge Biotherapeutics to enhance solutions for idiopathic pulmonary fibrosis
Korea | News | 0 Comment | 19 Apr, 2022
Bridge Biotherapeutics, a South Korean clinical-stage biotechnology company focused on developing novel drugs for fibros...Read more
